As our listeners will know, StartUp Health invests in what we call health moonshots. These are big, audacious health goals that guide us as we push innovative health entrepreneurs — our global army of Health Transformers — to collaborate and focus on long-term impact. We have health moonshots around curing cancer, improving women’s health, ending the opioid crisis, and we’ve recently added another focused on Type 1 diabetes.
This week, we launched a Health Equity Moonshot at the Clinton Global Initiative in order to build a framework that re-orients these inspiring problem solvers to tackle the challenge beneath the challenge, the social and systemic factors that drive health inequities. This transformative initiative will be integrated into all of StartUp Health’s other health moonshots, breaking down silos and encouraging local and global collaboration.
Leading StartUp Health’s Health Equity Moonshot is Kaakpema “KP” Yelpaala, a global health entrepreneur and long-time Health Transformer (he is the CEO & Co-founder of StartUp Health portfolio company InOn Health) who has dedicated his life to reducing health disparities. Yelpaala is an American of Ghanaian heritage and sits at the intersection of the immigrant and Black experiences in the United States.
In this StartUp Health NOW podcast episode, Yelpaala will share his vision for a Health Equity Moonshot and why it is necessary today.
Want to join this Health Equity Moonshot? If you’re an investor who believes in this vision, we want to hear from you. Are you a founder focused on breaking down health barriers for historically marginalized communities or who has been held back based on systemic bias in race, ethnicity, gender, or sexual orientation? We want to hear from you.
Investors: How to invest in StartUp Health Moonshots healthmoonshots.com
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content.
Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.